Phenylketonuria Market Research Report by Manufacturers, Region, Type and Application, Forecast to 2026

The Phenylketonuria market accounted for around USD 858.2 million in 2018 and is expected to grow at a CAGR of 6.3% during the forecast period, 2019–2026.

Phenylketonuria is an inborn genetic disorder, in which decreased metabolism of the amino acid phenylalanine. It is a rare genetic disorder that increases the level of phenylalanine in the blood and causes problems throughout the body. Phenylketonuria is major causes of seizures, intellectual disability, mental disorder, and behavioral problems.high prevalence of phenylketonuria across the globe is driving the growth of market. For instance, according to the Boston Children's Hospital, around one in 15,000 babies are born with PKU in the United States every year.

North America is dominating the market and expected to grow over forecast period.According to the CanPKU in U.S.  Phenylketonuria test is recommended as the first condition widely tested for through newborn screening. Increasing research and development and development for development of advanced treatment is propelling the growth of market. For instance, May 2018, U.S. Food and Drug Administration approved Palynziq (pegvaliase-pqpz) for treatment of phenylketonuria.

Europe accounted for second largest share for phenylketonuria market. Increasing number incidences of phenylketonuria in several European countries is boosting the growth of market. For instance, according to the NHS England, during 2015–2016, it was estimated approximately, 1 per 10,000/14,000 diagnosed with phenylketonuria. Furthermore, Different nonprofit organization work for management of phenylketonuria is fueling the growth of market. For instance, - European Society for Phenylketonuria and Allied Disorders, has been published in the Orphanet Journal of Rare Diseases for increasing awareness of phenylketonuria.

Get a Sample Copy of this report with the latest Industry trends and COVID-19 Impact: 
https://straitsresearch.com/report/phenylketonuria-market/request-sample

The Major Players Covered in this Report:
ambrooke Therapeutics, Daiichi Sankyo Company Limited, American Gene Technologies International, Inc., Danone Nutricia, Dimension Therapeutics, Inc., Synthetic Biologics, Inc., SOM Innovation Biotech SL, Codexis, Inc., BioMarin Pharmaceutical, Inc., and Erytech Pharma SA, among others., & More...

By Product Type, Drugs, Kuvan, Biopten, Dietary Supplement
By Rout of Administration, Oral Route, Tablets and Capsules, Syrups, Powder, Parenteral Route, Intravenous, Subcutaneous
By Distribution Channel, Hospital Pharmacies, Drug Stores, Online Pharmacies, Pediatric Clinics

Buy Full Report with Detail Analysis with COVID-19 Impact – 
https://straitsresearch.com/buy-now/phenylketonuria-market/global/

Growing Domestic Demand and Expanding Pharmaceutical Sector to Drive the Demand for Phenylketonuria in the APAC Region:
Asia-Pacific region is anticipated to hold the largest market share in the global Phenylketonuria market during the forecast period 2019-2026. The growth in this region can be attributed to the presence of emerging economies like India, China, Japan, Vietnam, and Indonesia, which account for the largest share in this region. India is one of the largest producers of Phenylketonuria and a major exporter of the product to various countries across the globe. India accounts for around 80% of the world’s exports of Phenylketonuria. The favorable climatic conditions and growth of agricultural inputs and allied services like cold storage and warehousing in India are prompting higher production.

View this report with a detailed description and TOC @ 
https://straitsresearch.com/report/phenylketonuria-market/toc

What will be the Future Developments in Phenylketonuria Market?
Historical inferences, findings & analysis of the market from 2016 to 2018
Projections and performance forecast analysis for the future from 2019 to 2026
Production and consumption point of view (POV) analysis
Market drivers, restraint and opportunity analysis, to define market dynamics covering industry, regulatory, innovation, technological & pricing trends
Comprehensive competitive landscape mapping with recent development covering market leadership, competency, sustainability, and prospects

View Full Report @ https://straitsresearch.com/report/phenylketonuria-market/

For more details, please contact us -
Straits Research
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY 10022
Tel: +1 646 480 7505, +44 208 068 9665
Website: https://straitsresearch.com/

About Us:
Regardless of whether you're looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with what customers purchase. We overcome the issues of our customers by recognizing and deciphering just the target group, while simultaneously generating leads with the highest precision. We seek to collaborate with our customers to deliver a broad spectrum of results through a blend of market and business research approaches.

This release was published on openPR.